Evaro

Evaro

Private
NorwichHealthcare & Life Scienceshttps://evaro.com

Last Round

Series A

Jan 27, 2026

Total Funding Raised

$26.5M

Momentum Score

25 /100

Company Overview

Evaro is a digital health company that provides a B2B "pharmaceutical infrastructure as a service" platform, enabling consumer brands to seamlessly integrate prescription medication services.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Platform-as-a-Service, Vertical SaaS, Medical AI, Pharma Supply Chain

Business Model

B2B2C

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

healthcare as a servicehealthcare APIembedded healthcarewhite-label healthcareclinical infrastructureasynchronous consultationsdigital pharmacytelemedicinetelehealthprivate prescriptionsmedical AImedication deliveryB2B2C healthcareremote diagnosticsemployee health benefits

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Evaro Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Evaro Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJan 27, 2026
SeedJan 31, 2024

Key People

Founding team and executive leadership

Thuria Wenbar

Chief Executive Officer

Executive Team

Alasdair Allan

Interim Chief Technology Officer

Executive Team

Sherral Toth

CTO Associate

Executive Team

Benedick Beeson

Chief Financial Officer

Executive Team

Evaro Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 27, 2026

    $25M round completed.

  • Jan 27, 2026

    Christoph Ruedig joins the board of directors.

Evaro Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Evaro Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Evaro's valuation, stock price, and market status.

Firmographic Details

HeadquartersNorwich
Employee Range76
Year Founded2017
Last FundingJan 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.